Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,091.68%
#4 Black Phoenix Black Phoenix +336.08%
#5 aPriori aPriori +112.62%
#6 Bedrock Bedrock +74.62%
#7 Cysic Cysic +47.27%
#8 Prom Prom +41.40%
#9 Playnance Playnance +34.98%
#10 COTI COTI +31.11%
Coin of the day
Wrapped One Wrapped One
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Clasificación en acciones #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Precio por acción
$0.00023723
Última sincronización: 2024-08-26
Capitalización bursátil
$1.41K
Cambio (1 día)
111.67%
Cambio (1 año)
0.00%
País
FR
Comercio Pharnext S.A. (ALPHA)

Categoría

Healthcare
Ratio P/S de Pharnext S.A. (ALPHA)
Ratio P/S al August 2026 TTM: 0.12
Según los informes financieros más recientes y el precio de las acciones de Pharnext S.A., el ratio P/S actual (TTM) es 0.12. Al final de 2022, el ratio P/S era 17.807T.
Historial del ratio P/S de Pharnext S.A. desde 2012 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 0.12 -99.84%
2023 73.60 -100.00%
2022 17.807T -99.54%
2021 3.91Qa -97.44%
2020 152.45Qa 270.01%
2019 41.20Qa 1,356.30%
2018 2.83Qa -40.90%
2017 4.79Qa 24.33%
2016 3.85Qa -46.55%
2015 7.20Qa 4.78%
2014 6.87Qa -4.45%
2013 7.19Qa 0.00%
2012 0.00 0.00%
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 8,203.19%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 8,557.98%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 4,084.29%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR